Tredje AP fonden Takes $1.85 Million Position in Encompass Health Co. (NYSE:EHC)

Tredje AP fonden acquired a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 20,000 shares of the company's stock, valued at approximately $1,847,000.

A number of other institutional investors have also recently added to or reduced their stakes in EHC. MassMutual Private Wealth & Trust FSB boosted its holdings in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after buying an additional 137 shares in the last quarter. Avior Wealth Management LLC purchased a new stake in Encompass Health during the third quarter worth about $40,000. Tompkins Financial Corp purchased a new stake in Encompass Health during the fourth quarter worth about $46,000. V Square Quantitative Management LLC lifted its holdings in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc purchased a new stake in shares of Encompass Health in the third quarter valued at about $68,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.10% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Barclays upped their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Finally, William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $107.67.

Encompass Health Trading Up 1.5 %

EHC stock traded up $1.46 on Wednesday, hitting $99.10. 513,766 shares of the company were exchanged, compared to its average volume of 632,270. Encompass Health Co. has a twelve month low of $76.11 and a twelve month high of $104.55. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The business's fifty day moving average is $97.60 and its two-hundred day moving average is $97.05. The stock has a market capitalization of $9.98 billion, a price-to-earnings ratio of 22.22, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, research analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's payout ratio is currently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.